World ADC Event Series’ Post

View organization page for World ADC Event Series, graphic

956 followers

Looking to transform your ADC target selection by identifying novel or repurposing already clinically validated targets to make best and first-in-class ADCs? Look no further than the 3rd ADC Target Selection Summit coming to Boston, MA this December🧪 As the ADC target space becomes increasingly saturates for well-understood clinically validated targets such as HER2 and TROP2, heads are now turning to identify novel targets amenable to ADCs and leverage improvements in linker-payload technologies to develop first-in-class or best-in-class ADCs. Sessions as part of the 3rd ADC Target Selection Summit include: 🧬Harnessing Target Specificity with Novel ADC Technology Advancements to Minimize Off-Target Toxicity 🧬Validating Novel ADC Targets for Progression into the Clinic 🧬Examining What Makes a Good ADC Target for Your Technology 🧬Optimizing Pairing of Target, Antibody & Linker-Payload Technologies 🧬Advancing Your Understanding of Target Biology to Aid in Target Selection Join expert speakers from AbbVieAngiex Inc.AstraZenecaAtreca, Inc.Bicycle TherapeuticsBolt Biotherapeutics, Inc. ,  DynamiCure BiotechnologyHillstream BioPharmaIksuda TherapeuticsInnovent BiologicsMerck Group ., SeagenSutro Biopharma, Inc., ZielBio, Inc., and many more! Learn more here ---> https://ter.li/3xhd4f #worldadc #antibodydrugconjugates #targetselection #her2 #drugdevelopment #adc

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics